Long‑lasting relief from nasal airway obstruction and chronic rhinitis is now within reach.

Finally, there are effective, office-friendly solutions for treating nasal obstruction and chronic rhinitis from Aerin® Medical.

Nasal airway obstruction (NAO) and chronic rhinitis are chronic nasal conditions that affect millions of patients. When medical therapies fall short, patients can turn to VivAer® and RhinAer® – two non‑invasive treatments that deliver significant, lasting relief and can be conveniently and safely performed right in the doctor’s office.

20,000,000

NAO SUFFERERS IN THE US1

30,000,000

Non-Allergic Rhinitis SUFFERERS IN THE US2

60,000,000

Allergic Rhinitis SUFFERERS IN THE US2

EFFICIENT. EFFECTIVE. NON-INVASIVE.

The compact Aerin touch-screen console pairs with the VivAer or RhinAer stylus to deliver precise, tissue-sparing, temperature-controlled radiofrequency (RF). Physicians can choose between two effective treatment options: VivAer for nasal airway obstruction or RhinAer for chronic rhinitis. Both VivAer and RhinAer fit seamlessly into the doctor’s office or operating room.

TWO POWERFUL TREATMENTS. DURABLE RESULTS.

VivAer: The Non‑Invasive Solution for Nasal Airway Obstruction

Enables a physician to effectively treat the core causes of nasal airway obstruction.

  • Single solution that can be used to treat the lateral wall, inferior turbinate, and septal swell body
  • Durably remodels soft tissue, including cartilage, in the nasal valve
  • Treatment does not alter patient aesthetics
  • Incisionless and can be performed under local anesthesia
Patients Health Care Providers

RhinAer: The Comprehensive Solution for Chronic Rhinitis

A comprehensive treatment for chronic rhinitis that provides long-lasting relief from runny nose, post-nasal drip, congestion, itching, and sneezing symptoms.

  • Disrupts posterior nasal nerve (PNN) that triggers rhinitis
  • May be used to treat full length of inferior turbinate
  • Treats both rhinorrhea and congestion
  • Effective for both allergic and nonallergic rhinitis
  • Incisionless and can be performed under local anesthesia
Patients Health Care Providers

References:

  1. Value calculated based on 2014 US population estimate from US Census and World Bank data in conjunction with incidence numbers cited in: Stewart M, Ferguson BJ, Fromer L. Epidemiology and burden of nasal congestion. Intl J Gen Med. 2010;3:37-45.
  2. Scarupa MD, Kaliner MA. Nonallergic rhinitis, with a focus on vasomotor rhinitis: clinical importance, differential diagnosis, and effective treatment recommendations. World Allergy Organ J. 2009;2(3):20-25. doi10.1097/WOX.0b013e3181990aac.